October 1, 2024
“…UiPath: 212% implied upside… Going forward, Wall Street expects UiPath to grow sales at 10% annually through fiscal 2026 (ends April 2026). That estimate leaves room for upside because the RPA market is forecasted to grow at 40% annually through… Continue Reading…
September 30, 2024
“…Energy Transfer is having a strong year. Its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) increased 20% in the second quarter to almost $3.8 billion. Meanwhile, its distributable cash flow surged 32% to over $2 billion… Energy Transfer’s capital project… Continue Reading…
September 18, 2024
“…1. United Parcel Service There’s no getting around the fact that the wind-down of the COVID-19 pandemic has proven challenging for United Parcel Service (NYSE: UPS). The stock soared in the wake of a wave of online shopping, but the return of… Continue Reading…
September 4, 2024
“…COMPASS Pathways (CMPS)… Morgan Stanley analyst Vikram Purohit, who covers the stock, sees CMPS as presenting a compelling risk-reward opportunity. He highlights the company’s leading clinical program… To this end, Purohit rates CMPS shares an Overweight (i.e. Buy), and his $23 price… Continue Reading…
August 12, 2024
https://finance.yahoo.com/news/intel-crashed-30-stock-sell-091500373.html I’m not going to read this. I don’t think it is. My opinion on long term stocks is unless its energy or commodes in general its better to wait to invest after the market crashes. There are exceptions but… Continue Reading…
August 12, 2024
“CervoMed (CRVO) The first Morgan Stanley pick we’ll look at is CervoMed, a clinical-stage medical research firm specializing in neurodegenerative diseases and conditions… Overall, the analyst expects positive clinical results and rates CRVO an Overweight (i.e., Buy). His $35 price… Continue Reading…
July 31, 2024
“…RegenXBio (RGNX) The first Goldman pick we’ll look at is RegenXBio, a gene therapy company specializing in single-dose treatments for severe diseases with few or no existing therapies…. Choi rates RGNX a Buy along with a $38 price target. This… Continue Reading…
July 8, 2024
“Semiconductor company Nvidia (NASDAQ: NVDA) completed a 10-for-1 stock split in June, and fellow chipmaker Broadcom (NASDAQ: AVGO) has a 10-for-1 stock split planned for July. Savvy investors have gravitated toward both stocks. A company’s share price tends to increase about twice as fast as the S&P 500 (SNPINDEX:… Continue Reading…
July 8, 2024
“Boeing said Monday that it will buy back its struggling fuselage maker Spirit AeroSystems in an all-stock deal that the plane maker has said will improve safety and quality control. It said it agreed to pay $37.25 a share in Boeing stock for… Continue Reading…
July 1, 2024
“…Why are investors downbeat on Agree Realty? The backstory with Agree is a fairly good one. Then why is the REIT’s share price down around 20% or so from its 2022 highs?… The good news here is that the problem… Continue Reading…
Recent Comments